43
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Increased gene copy number of the vesicle SNARE VAMP7 disrupts human male urogenital development through altered estrogen action

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Vesicle transport is intimately connected with key nuclear functions and transcriptional regulation. Here, children born with congenital genitourinary tract masculinization disorders were analyzed by array-Comparative Genomic Hybridization, which revealed the presence of de novo copy number gains on Xq28 encompassing the VAMP7 gene encoding a vesicle-trafficking protein. Humanized VAMP7 BAC transgenic mice displayed cryptorchidism, urethral defects, and hypospadias. Mutant mice exhibited reduced penile length, focal spermatogenic anomalies, diminished sperm motility, and subfertility. VAMP7 colocalized with estrogen receptor alpha (ESR1) in the presence of ligand. Elevated levels of VAMP7 markedly intensified ESR1 transcriptional activity by increasing ESR1 protein cellular content upon ligand stimulation and up-regulated the expression of estrogen-responsive genes including ATF3, CYR61, and CTGF, all of which are implicated in human hypospadias. Hence, increased gene dosage of the SNARE protein, VAMP7, enhances estrogen receptor action in male genitourinary tissues, affects the virilization of the reproductive tract, and results in genitourinary birth defects in humans.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems.

          The ubiquitin proteasome system (UPS) and macroautophagy (hereafter called autophagy) were, for a long time, regarded as independent degradative pathways with few or no points of interaction. This view started to change recently, in the light of findings that have suggested that ubiquitylation can target substrates for degradation via both pathways. Moreover, perturbations in the flux through either pathway have been reported to affect the activity of the other system, and a number of mechanisms have been proposed to rationalise the link between the UPS and autophagy. Here we critically review these findings and outline some outstanding issues that still await clarification. Copyright 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates

            Summary The two main routes that cells use for degrading intracellular proteins are the ubiquitin-proteasome and autophagy-lysosome pathways, which have been thought to have largely distinct clients. Here, we show that autophagy inhibition increases levels of proteasome substrates. This is largely due to p62 (also called A170/SQSTM1) accumulation after autophagy inhibition. Excess p62 inhibits the clearance of ubiquitinated proteins destined for proteasomal degradation by delaying their delivery to the proteasome's proteases. Our data show that autophagy inhibition, which was previously believed to only affect long-lived proteins, will also compromise the ubiquitin-proteasome system. This will lead to increased levels of short-lived regulatory proteins, like p53, as well as the accumulation of aggregation-prone proteins, with predicted deleterious consequences.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Human copy number variation and complex genetic disease.

              Copy number variants (CNVs) play an important role in human disease and population diversity. Advancements in technology have allowed for the analysis of CNVs in thousands of individuals with disease in addition to thousands of controls. These studies have identified rare CNVs associated with neuropsychiatric diseases such as autism, schizophrenia, and intellectual disability. In addition, copy number polymorphisms (CNPs) are present at higher frequencies in the population, show high diversity in copy number, sequence, and structure, and have been associated with multiple phenotypes, primarily related to immune or environmental response. However, the landscape of copy number variation still remains largely unexplored, especially for smaller CNVs and those embedded within complex regions of the human genome. An integrated approach including characterization of single nucleotide variants and CNVs in a large number of individuals with disease and normal genomes holds the promise of thoroughly elucidating the genetic basis of human disease and diversity.
                Bookmark

                Author and article information

                Journal
                9502015
                8791
                Nat Med
                Nat. Med.
                Nature medicine
                1078-8956
                1546-170X
                23 May 2014
                01 June 2014
                July 2014
                05 January 2015
                : 20
                : 7
                : 715-724
                Affiliations
                [1 ]Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA
                [2 ]Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, Sophia Antipolis, France
                [3 ]Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA
                [4 ]Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen, UK
                [5 ]Centre Méditerranéen de Médecine Moléculaire, INSERM U1065, Nice, France
                [6 ]Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
                [7 ]Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX, USA
                Author notes
                [§ ]Corresponding authors: Mounia Tannour-Louet, Ph.D.; mounia.louet@ 123456gmail.com and Dolores J. Lamb, Ph.D.; dlamb@ 123456bcm.edu
                [#]

                Equally contributing authors

                Article
                NIHMS589175
                10.1038/nm.3580
                4283218
                24880616
                adcd1165-d6d8-4474-9cad-39f873ef99b3
                History
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article